Procter & Gamble (NYSE:PG – Get Rating) had its price target reduced by investment analysts at Truist Financial from $175.00 to $160.00 in a research note issued to investors on Monday, The Fly reports. The firm presently has a “buy” rating on the stock. Truist Financial’s price target would indicate a potential upside of 12.72% from the stock’s current price.
A number of other equities research analysts also recently commented on PG. Jefferies Financial Group lifted their target price on shares of Procter & Gamble from $179.00 to $185.00 in a research report on Thursday, April 21st. Barclays decreased their price target on shares of Procter & Gamble from $176.00 to $157.00 and set an “overweight” rating on the stock in a research note on Monday, May 23rd. Raymond James reiterated a “maintains” rating on shares of Procter & Gamble in a research note on Monday, July 25th. Evercore ISI set a $170.00 target price on shares of Procter & Gamble in a research report on Monday, June 20th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of Procter & Gamble from $171.00 to $157.00 and set a “buy” rating on the stock in a research report on Tuesday, June 21st. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $162.93.
Procter & Gamble Price Performance
Shares of NYSE PG opened at $141.95 on Monday. The stock has a market cap of $340.58 billion, a PE ratio of 24.43, a price-to-earnings-growth ratio of 4.31 and a beta of 0.36. Procter & Gamble has a fifty-two week low of $129.50 and a fifty-two week high of $165.35. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.45 and a current ratio of 0.65. The stock has a fifty day moving average of $143.02 and a 200-day moving average of $151.29.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO Sundar G. Raman sold 1,599 shares of Procter & Gamble stock in a transaction on Thursday, July 7th. The shares were sold at an average price of $145.12, for a total value of $232,046.88. Following the completion of the transaction, the chief executive officer now owns 4,002 shares of the company’s stock, valued at $580,770.24. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.51% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. PrairieView Partners LLC lifted its position in shares of Procter & Gamble by 5.8% in the 1st quarter. PrairieView Partners LLC now owns 1,141 shares of the company’s stock worth $174,000 after purchasing an additional 63 shares during the period. Apeiron RIA LLC grew its position in shares of Procter & Gamble by 2.2% in the first quarter. Apeiron RIA LLC now owns 2,985 shares of the company’s stock valued at $475,000 after purchasing an additional 64 shares during the period. Ambassador Advisors LLC lifted its stake in shares of Procter & Gamble by 2.2% in the fourth quarter. Ambassador Advisors LLC now owns 3,033 shares of the company’s stock worth $496,000 after buying an additional 65 shares in the last quarter. Perennial Investment Advisors LLC lifted its stake in shares of Procter & Gamble by 1.1% in the first quarter. Perennial Investment Advisors LLC now owns 5,889 shares of the company’s stock worth $900,000 after buying an additional 65 shares in the last quarter. Finally, Tranquility Partners LLC raised its stake in Procter & Gamble by 3.9% during the first quarter. Tranquility Partners LLC now owns 1,757 shares of the company’s stock worth $268,000 after purchasing an additional 66 shares during the period. 63.64% of the stock is owned by institutional investors and hedge funds.
Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care.
See Also
- Get a free copy of the StockNews.com research report on Procter & Gamble (PG)
- 3 Health Care Stocks in Great Financial Health
- Amazon Names Itself A Top Stock Of Q3 Contender
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Earnings Announcements That Could Surprise
- Pinterest Shares Are Soaring After Earnings, Is The Stock A Buy?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.